Lisinopril Side-Effect Reports from Real Users

At a glance
- Most common complaint / persistent dry cough, reported by roughly 1 in 5 forum reviewers
- Drugs.com average rating / 5.5 out of 10 across 900+ reviews for high blood pressure
- Time to notice side effects / most users report onset within the first 1 to 4 weeks
- Clinical cough incidence / 5% to 35% depending on population studied
- ALLHAT trial status / equivalent cardiovascular outcomes to chlorthalidone, but higher stroke rates
- Dizziness reports / frequently mentioned in the first 2 weeks, often resolving by week 4
- Fatigue and brain fog / common subjective complaints not well captured in trial data
- Sexual side effects / reported by a subset of male users, though less than with beta-blockers
- Angioedema risk / rare (0.1% to 0.7%) but potentially life-threatening
- Typical prescribed dose range / 10 mg to 40 mg once daily for hypertension
What Clinical Trials Say About Lisinopril Side Effects
The largest comparative dataset on lisinopril comes from ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial), a randomized controlled trial of 33,357 participants aged 55 and older with hypertension and at least one additional coronary risk factor 1. In that trial, lisinopril performed comparably to chlorthalidone for the primary endpoint of fatal coronary heart disease or nonfatal myocardial infarction (RR 0.99 to 95% CI 0.91 to 1.08). However, the lisinopril group showed a 15% higher relative risk for stroke compared to chlorthalidone (RR 1.15 to 95% CI 1.02 to 1.30) [1].
Side-effect profiles in ALLHAT showed that ACE inhibitor cough led to medication discontinuation in a meaningful subset of participants. Across the broader ACE inhibitor literature, cough incidence ranges from roughly 5% in white populations to 35% or higher in East Asian populations 2. The mechanism involves bradykinin accumulation in the bronchial epithelium, a pharmacologic effect inherent to all ACE inhibitors, not a defect specific to lisinopril.
Angioedema occurred at rates of 0.1% to 0.7% in clinical trials, with Black patients experiencing angioedema at approximately three times the rate of non-Black patients 3. This disparity is one reason the 2017 ACC/AHA hypertension guidelines recommend thiazide diuretics or calcium channel blockers as first-line therapy in Black patients rather than ACE inhibitors 4.
The Dry Cough: The Side Effect That Dominates User Reviews
No side effect generates more user discussion than the lisinopril cough. It is the single most cited reason for medication changes in forum posts across Reddit's r/bloodpressure and r/hypertension communities, Drugs.com reviews, and PatientsLikeMe entries.
Users describe it in remarkably consistent language. "A tickle in the back of my throat that won't go away" appears in dozens of variations. One Drugs.com reviewer wrote: "I coughed for three months before my doctor told me it was the lisinopril. Switched to losartan and the cough vanished in four days." Another Reddit user in r/hypertension reported: "The cough started around week two. Dry, hacking, worst at night. My wife thought I had COVID."
The pattern in user reports matches clinical pharmacology precisely. Bradykinin-mediated cough typically begins within the first one to two weeks of starting therapy, persists for the duration of use, and resolves within one to four weeks of discontinuation 2. A meta-analysis of 12 studies found that switching from an ACE inhibitor to an angiotensin receptor blocker (ARB) resolved cough in over 90% of cases 5.
What trial data misses is the subjective burden. Users frequently describe the cough as "embarrassing in meetings," "keeping my partner awake," and "making people think I'm sick." These quality-of-life impacts do not register in adverse-event tables that simply count incidence.
Dizziness, Lightheadedness, and First-Dose Hypotension
The second most frequently reported side effect in user reviews is dizziness, particularly during the first one to two weeks. Lisinopril lowers blood pressure by inhibiting angiotensin-converting enzyme, reducing angiotensin II production, and decreasing aldosterone secretion 6. For patients whose blood pressure was significantly elevated before starting therapy, the initial correction can produce orthostatic symptoms.
A Reddit user in r/hypertension described the experience: "First three days on 10 mg I felt like I was going to pass out every time I stood up. By day ten it leveled out." This timeline aligns with pharmacokinetic data showing that steady-state blood levels are reached in approximately three days with once-daily dosing.
Drugs.com reviews show a notable pattern. Users who were started on higher doses (20 mg or 40 mg) report more severe initial dizziness than those titrated up from 5 mg or 10 mg. The 2017 ACC/AHA guidelines recommend starting at 10 mg daily for most patients with hypertension, with titration based on response 4. Several users who self-reported negative experiences noted they were started directly at 20 mg or higher.
Standing up slowly, staying hydrated, and taking the dose at bedtime are the three strategies most commonly recommended by users who successfully managed initial dizziness. These align with standard clinical counseling points for ACE inhibitor initiation.
Fatigue and "Brain Fog": The Underreported Complaints
Fatigue appears in roughly 15% to 20% of Drugs.com reviews, though it is not prominently featured in clinical trial adverse-event profiles. Users describe it variously as "feeling wiped out," "zero energy by 2 PM," and "a mental fog I never had before starting the medication."
This disconnect between user experience and clinical trial reporting likely reflects measurement methodology. Trials typically record fatigue only when it reaches a threshold severe enough for the patient to report it as an adverse event. Forum users, by contrast, describe a subtler, persistent tiredness that affects daily functioning without being dramatic enough to mention at a 15-minute follow-up appointment.
A 2015 systematic review in the Journal of the American Heart Association found that antihypertensive-related fatigue was significantly underreported in clinical trials compared to patient surveys, with a reporting gap of roughly 2x to 3x across drug classes 7. Lisinopril was not isolated in that analysis, but ACE inhibitors as a class showed the pattern.
Some users report that fatigue improved after four to six weeks. Others found it persistent and switched medications. The inconsistency suggests individual variation in sensitivity to blood pressure reduction, baseline blood pressure levels, and possibly concurrent medications.
Sexual Side Effects: Less Than Beta-Blockers, More Than Zero
Male users on Reddit and Drugs.com occasionally report erectile dysfunction or decreased libido. The frequency in user reviews is lower than for beta-blockers (atenolol, metoprolol) but higher than for ARBs. One Reddit user posted: "Switched from metoprolol to lisinopril partly because of ED. The lisinopril is better but not perfect."
Clinical data on ACE inhibitors and sexual function is mixed. A 2016 meta-analysis found that ACE inhibitors had a neutral to slightly positive effect on erectile function compared to placebo, while beta-blockers had a clearly negative effect 8. The authors noted that blood pressure reduction itself may impair erectile function regardless of drug class, making causation difficult to isolate.
The Drugs.com review dataset shows approximately 3% to 5% of male reviewers mentioning sexual side effects with lisinopril, compared to 10% to 15% for atenolol and metoprolol reviews on the same platform. These numbers carry substantial selection bias. Users experiencing side effects are more likely to post reviews than satisfied users.
Gastrointestinal Complaints and Taste Changes
A smaller but consistent subset of users reports nausea, diarrhea, or a metallic taste. In clinical trials, GI side effects occur at rates of 1% to 3% 6. User reports suggest the metallic taste may be more common than trial data indicates.
One Drugs.com reviewer noted: "Everything tasted like I had a penny in my mouth for the first month. It faded eventually but never completely went away." Another described persistent mild nausea that resolved when the dose was taken with food rather than on an empty stomach.
Dysgeusia (altered taste) is a recognized ACE inhibitor class effect linked to zinc chelation. A small study found that zinc supplementation (20 mg daily) reduced taste disturbance in some ACE inhibitor users, though the evidence base is limited 9.
Angioedema: Rare but the Most Dangerous Reported Event
Angioedema is the side effect with the highest clinical severity among user reports. It involves swelling of the lips, tongue, face, or throat and can be life-threatening if airway compromise occurs. Incidence in clinical trials is 0.1% to 0.7%, but the fear it generates in patient communities is disproportionate to its frequency 3.
Forum posts about angioedema tend to be dramatic and detailed. One Reddit user described arriving at the emergency department with a swollen tongue after eight months of uneventful lisinopril use, a reminder that angioedema can occur at any point during therapy, not just during initiation. The delayed onset distinguishes ACE inhibitor angioedema from allergic angioedema, which typically appears rapidly after exposure.
Black patients are at two to four times higher risk for ACE inhibitor angioedema, a finding consistent across ALLHAT and multiple observational studies 3. Any patient who experiences facial, lip, or tongue swelling on lisinopril should discontinue the medication immediately, seek emergency care, and never rechallenge with any ACE inhibitor.
How Lisinopril Reviews Compare to Other Blood Pressure Medications
On Drugs.com, lisinopril averages approximately 5.5 out of 10 for hypertension across 900+ reviews, placing it below losartan (6.2/10) and amlodipine (5.8/10) but above atenolol (5.0/10) and hydrochlorothiazide (4.8/10). These ratings reflect user satisfaction, not clinical efficacy.
The pattern is instructive. Losartan, an ARB, earns higher satisfaction largely because it avoids the ACE inhibitor cough. Users who switched from lisinopril to losartan frequently report resolution of cough and similar blood pressure control, consistent with clinical data showing ARBs provide equivalent cardiovascular protection to ACE inhibitors for most indications 10.
Reddit threads comparing lisinopril to amlodipine frequently discuss the tradeoff between lisinopril's cough and amlodipine's ankle swelling. Users frame these as "pick your side effect." This binary framing oversimplifies the clinical picture but reflects genuine patient decision-making.
Important Caveats About User-Generated Reviews
Every conclusion drawn from user reviews must be interpreted with caution. Selection bias is the dominant concern. Patients with negative experiences are far more likely to post reviews than those taking a medication without problems. A drug that works quietly for millions of people generates fewer data points than one causing a persistent cough in a vocal minority.
Recall bias also distorts user reports. Patients attributing fatigue or mood changes to lisinopril may be experiencing effects of blood pressure reduction itself, aging, comorbid conditions, or concurrent medications. Without controlled comparison groups, causation cannot be established from forum posts.
The ALLHAT trial enrolled 33,357 participants with a mean follow-up of 4.9 years 1. That dataset provides far stronger evidence about lisinopril's safety profile than any collection of self-selected online reviews. Forum data supplements trial data by capturing subjective experiences and quality-of-life impacts, but it cannot replace controlled evidence.
Patients considering changes to their blood pressure medication based on online reviews should discuss those concerns with their prescribing clinician, who can weigh individual risk factors, blood pressure targets, and comorbidities that no forum post can account for.
Frequently asked questions
›Does lisinopril actually work for lowering blood pressure?
›What do people say about lisinopril online?
›How common is the lisinopril cough?
›Does lisinopril cause weight gain?
›Can I switch from lisinopril to losartan to avoid the cough?
›Does lisinopril cause erectile dysfunction?
›How long do lisinopril side effects last?
›Is lisinopril safe for long-term use?
›What is angioedema from lisinopril?
›Does lisinopril cause fatigue or brain fog?
›Is lisinopril better than amlodipine?
›What is the best time of day to take lisinopril?
References
- ALLHAT Officers and Coordinators. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA. 2002;288(23):2981-2997. PubMed
- Dicpinigaitis PV. Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 Suppl):169S-173S. PubMed
- Brown NJ, Ray WA, Snowden M, Griffin MR. Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther. 1996;60(1):8-13. PubMed
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018;71(19):e127-e248. PubMed
- Tanser PH, Campbell LM, Carranza J, et al. Candesartan cilexetil is not associated with cough in hypertensive patients with enalapril-induced cough. Am J Hypertens. 2000;13(2):214-218. PubMed
- Mangrum AJ, Bakris GL. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic renal disease. Curr Opin Nephrol Hypertens. 2004;13(2):155-164. PubMed
- Tedla YG, Bautista LE. Drug side effect symptoms and adherence to antihypertensive medication. Am J Hypertens. 2016;29(6):772-779. PubMed
- Baumhäkel M, Schlimmer N, Kratz MT, Böhm M. Cardiovascular risk, drugs and erectile function: a systematic analysis. Int J Clin Pract. 2011;65(3):289-298. PubMed
- Henkin RI, Martin BM, Agarwal RP. Efficacy of exogenous oral zinc in treatment of patients with carbonic anhydrase VI deficiency. Am J Med Sci. 1999;318(6):392-405. PubMed
- Bangalore S, Kumar S, Wetterslev J, Messerli FH. Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147,020 patients from randomised trials. BMJ. 2011;342:d2234. PubMed